We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.6B
AUM Growth
+$4.89B
(+15%)
Cap. Flow
+$2.25B
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
23.7%
Holding
2,051
New
98
Increased
1,226
Reduced
674
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$202M |
| 2 |
Linde
LIN
|
+$201M |
| 3 |
Apple
AAPL
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$187M |
| 5 |
Fastenal
FAST
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 2 |
IBM
IBM
|
+$38.3M |
| 3 |
Target
TGT
|
+$35M |
| 4 |
Sherwin-Williams
SHW
|
+$33.8M |
| 5 |
S&P Global
SPGI
|
+$32.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.52% |
| 2 | Industrials | 11.95% |
| 3 | Consumer Staples | 11.58% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Financials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Royalty Pharma
RPRX
$26.1B
| $951K | ﹤0.01% |
31,305
+2,764
| +10% | +$81.5K |
|
802
Dentsply Sirona
XRAY
$2.59B
| $949K | ﹤0.01% |
28,597
-737
| -3% | -$25.2K |
|
803
Brink's
BCO
$5.02B
| $946K | ﹤0.01% |
10,235
+221
| +2% | +$18.4K |
|
804
Marathon Digital Holdings
MARA
$4.62B
| $940K | ﹤0.01% |
41,626
+4,873
| +13% | +$106K |
|
805
Varonis Systems
VRNS
$5.25B
| $939K | ﹤0.01% |
19,910
+1,493
| +8% | +$71.1K |
|
806
Hasbro
HAS
$12.6B
| $935K | ﹤0.01% |
16,544
-425
| -3% | -$21.6K |
|
807
Sanofi
SNY
$104B
| $933K | ﹤0.01% |
19,197
+1,268
| +7% | +$61.9K |
|
808
Magnolia Oil & Gas
MGY
$5.83B
| $930K | ﹤0.01% |
35,851
+6,130
| +21% | +$134K |
|
809
Ares Capital
ARCC
$13.5B
| $930K | ﹤0.01% |
44,656
+6,992
| +19% | +$142K |
|
810
Moog Inc Class A
MOG.A
$13B
| $928K | ﹤0.01% |
5,813
+475
| +9% | +$69.9K |
|
811
Glaukos
GKOS
$9.02B
| $922K | ﹤0.01% |
9,780
+637
| +7% | +$56.9K |
|
812
Iovance Biotherapeutics
IOVA
$2.23B
| $922K | ﹤0.01% |
62,210
+7,891
| +15% | +$91.8K |
|
813
Coca-Cola Consolidated
COKE
$12.3B
| $920K | ﹤0.01% |
10,870
+510
| +5% | +$44K |
|
814
Hancock Whitney
HWC
$6.13B
| $912K | ﹤0.01% |
19,808
+901
| +5% | +$40K |
|
815
Jazz Pharmaceuticals
JAZZ
$15.9B
| $896K | ﹤0.01% |
7,439
+105
| +1% | +$12.9K |
|
816
Synaptics
SYNA
$4.41B
| $893K | ﹤0.01% |
9,149
+396
| +5% | +$41.6K |
|
817
Zurn Elkay Water Solutions
ZWS
$8.07B
| $891K | ﹤0.01% |
26,606
+2,095
| +9% | +$64.5K |
|
818
Goodyear
GT
$2.07B
| $885K | ﹤0.01% |
64,454
+2,901
| +5% | +$37.9K |
|
819
Signet Jewelers
SIG
$3.55B
| $883K | ﹤0.01% |
8,823
+445
| +5% | +$44.5K |
|
820
Belden
BDC
$4B
| $882K | ﹤0.01% |
9,524
+290
| +3% | +$23.6K |
|
821
Modine Manufacturing
MOD
$12.8B
| $881K | ﹤0.01% |
9,251
+727
| +9% | +$56.2K |
|
|
AXNX
822
DELISTED
Axonics, Inc. Common Stock
AXNX
| $880K | ﹤0.01% |
12,752
+4,517
| +55% | +$305K |
|
823
EnerSys
ENS
$6.95B
| $879K | ﹤0.01% |
9,309
+350
| +4% | +$32.9K |
|
824
Mohawk Industries
MHK
$6.9B
| $878K | ﹤0.01% |
6,711
-178
| -3% | -$20K |
|
825
Brookfield Infrastructure Partners
BIP
$18.8B
| $872K | ﹤0.01% |
27,944
-2,360
| -8% | -$71.6K |
|
Similar funds
ProShare Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, ProShare Advisors held 2,051 positions worth $37.6B, up 15% from $32.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $2.25B of net new capital in Q1 2024, opening 98 new positions and adding to 1,226 existing holdings. Its largest new stake was SS&C Technologies: 123,548 shares worth $7.95M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $163M trimmed.
- ProShare Advisors's largest Q1 2024 buy was SS&C Technologies: 123,548 shares worth $7.95M.
- ProShare Advisors added most to Microsoft in Q1 2024, an estimated $202M increase.
- ProShare Advisors's biggest Q1 2024 reduction was Walgreens Boots Alliance, cutting an estimated $163M.
- ProShare Advisors fully exited Splunk Inc in Q1 2024, selling an estimated $20.4M.
- ProShare Advisors's ten largest holdings make up 24% of its $37.6B portfolio in Q1 2024.
- ProShare Advisors opened 98 new positions and closed 47 in Q1 2024.
- ProShare Advisors's portfolio value rose 15% quarter-over-quarter to $37.6B.
Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.